Advertisement

Topics

Cordis Company Profile

20:06 EST 9th December 2018 | BioPortfolio

Nil

Location

Medical Research Council20 Park Crescent
London
London
W1B 1AL
United Kingdom

Contact

Phone: 00 44 (0) 020 7670 5274
Fax: 00 44 (0) 020 7670 5124
Email: fp6@headoffice.mrc.ac.uk


News Articles [6 Associated News Articles listed on BioPortfolio]

FDA Action Alert: Cordis and PneumRx

Although there are no U.S. Food and Drug Administration (FDA) approvals expected for this week, there are two Adcom meetings. Advisory Committees are used by the agency to obtain independent expert ad...

Cordis Corp Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryCordis Corporation Cordis, a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surger...

Cordis Corp Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryCordis Corporation Cordis, a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surger...

Cordis Corp Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryCordis Corporation Cordis, a subsidiary of a Cardinal Health Inc., develops and manufactures interventional vascular products in the area of cardiology as well as for use in endovascular surger...

Global Cerebral Vascular Stents Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Global Coronary Guidewires Market Status and Outlook 20182025 [Report Updated: 16082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Drugs and Medications [0 Results]

None

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Prenatal diagnosis of ectopia cordis in a twin fetus.

We report images of the 7th case worldwide of a twin fetus with a complete isolated ectopia cordis in a dichorionic diamniotic twin gestation. There is no consanguinity, family history of abnormalitie...

Diagnostic Criteria for Commotio Cordis Caused by Violent Attack: Review of the Literature.

The diagnosis of lethal commotio cordis (CC) is really complex. The forensic pathologist's task is even more relevant when he/she has to explain a CC diagnosis caused by an assault in a trial. The pur...

Nuances of Endovascular Treatment of Transverse/Sigmoid Sinus Stenosis With Stenting Venoplasty in a Patient With Pseudotumor Cerebri: 2-Dimensional Operative Video.

We present a case of a patient with pseudotumor cerebri (PC) and transverse/sigmoid junction sinus (TSJS) stenosis treated with stenting venoplasty. A 54-yr-old man with a history of hypertension, hyp...

Clinical Trials [27 Associated Clinical Trials listed on BioPortfolio]

Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)

The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdom...

The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System

To evaluate the safety and feasibility of the Cordis Neurovascular Self-Expanding Stent System to facilitate endovascular coil embolization of wide neck saccular intracranial aneurysms. ...

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent

This study will look at the performance of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System for the treatment of TASC C & D superficial femoral artery long lesions (up to 22 cm) i...

Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)

The primary objective of this study is to compare the safety and effectiveness of the Cordis Nitinol Carotid Stent and Delivery Systems (5.5 F and 7 F) with the ANGIOGUARD XP distal prote...

A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries

Feasibility study to assess safety of treating patients with self expanding stent in intracranial arteries.

Companies [3 Associated Companies listed on BioPortfolio]

Cordis Corporation

For more than 50 years, Cordis Corporation, a Johnson & Johnson company, has been a worldwide leader in the development and manufacture of interventional vascular technology. Thro...

Cordis

Nil

Flashpoint Medica

Flashpoint Medica, a member of the Omnicom Group (NYSE: OMC), is a full-service professional agency focused on defining a brand's flashpoints by bringing unexpected solutions to ignite a brand's g...

More Information about "Cordis" on BioPortfolio

We have published hundreds of Cordis news stories on BioPortfolio along with dozens of Cordis Clinical Trials and PubMed Articles about Cordis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cordis Companies in our database. You can also find out about relevant Cordis Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record